Natera ( (NTRA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Natera Inc.’s stock movement was influenced by its Q1 2025 earnings report, which revealed a strong 36.5% revenue increase driven by a rise in processed and oncology tests. Despite the impressive revenue growth, the company faced a net loss of $66.9 million, leading Barclays to lower its price target from $200 to $160 due to concerns about future profitability and margin pressures. Natera’s announcement of presenting promising trial results at an upcoming congress further highlights its strategic focus on expanding product offerings and operational efficiencies.
More about Natera
YTD Price Performance: 1.23%
Average Trading Volume: 1,709,682
Technical Sentiment Signal: Buy
Current Market Cap: $21.7B
For further insights into NTRA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.